SCHEMBL895221

SCHEMBL895221

C[C]1C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Xylene SCHEMBL33600 0.94
SCHEMBL28765948 0.80
Toluene SCHEMBL451397 0.76
SCHEMBL28972054 0.73
SCHEMBL9700070 0.73
SCHEMBL29043245 0.71
SCHEMBL15484301 0.67
SCHEMBL8758 0.63
SCHEMBL895220 0.63
SCHEMBL11792566 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117004698-A Double-ended sequencing method and kit 深圳赛陆医疗科技有限公司 2023-11-07 CN claimed
EP-3284739-A1 SUBSTITUTED (HET) ARYL COMPOUNDS AS PESTICIDES Bayer CropScience Aktiengesellschaft (DE) 2018-02-21 EP claimed
WO-2024149275-A1 KRAS INHIBITOR COMPOUND 上海湃隆生物科技有限公司 2024-07-18 WO disclosed
CN-118302504-A Preparation of renewable jet fuel from catalytic pyrolysis feedstock IFP 新能源公司 2024-07-05 CN disclosed
CN-118265764-A Preparation of renewable diesel from catalytic pyrolysis feedstock IFP 新能源公司 2024-06-28 CN disclosed
US-20240199654-A1 CTLA-4 SMALL MOLECULE DEGRADATION AGENT AND APPLICATION THEREOF SUZHOU GUOKUANG PHARMTECH. CO., LTD. (CN) 2024-06-20 US disclosed
US-20240189320-A1 HIGHLY ACTIVE STING PROTEIN AGONIST COMPOUND ADLAI NORTYE BIOPHARMA CO., LTD. (CN) 2024-06-13 US disclosed
EP-4382519-A1 CYCLIN K DEGRADATION AGENT Adlai Nortye Biopharma Co., Ltd. (CN) 2024-06-12 EP disclosed
CN-111655682-B High-activity STING protein agonist compound 杭州阿诺生物医药科技有限公司 2024-05-31 CN disclosed
US-20240165244-A1 BRM Targeting Compounds And Associated Methods Of Use PRELUDE THERAPEUTICS INCORPORATED 2024-05-23 US disclosed
WO-2024104364-A1 PAN-KRAS INHIBITOR COMPOUND 杭州阿诺生物医药科技有限公司 2024-05-23 WO disclosed
US-20100168468-A1 WRINKLE-PREVENTING AND IMPROVING COMPOSITION KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-07-01 US disclosed
EP-1908454-A1 WRINKLE-PREVENTIVE/AMELIORATING AGENT SHISEIDO COMPANY, LTD. (JP) 2008-04-09 EP disclosed
US-20070117720-A1 Compositions with cyclopropenes AGROFRESH, INC. 2007-05-24 US disclosed
EP-1787513-A2 Compositions with cyclopropenes Rohm and Haas Company (US) 2007-05-23 EP disclosed
CN-1965648-A Compositions with cyclopropenes ROHM & HAAS (US) 2007-05-23 CN disclosed
US-7052885-B2 Process for preparing heterocyclic (R)- and (S)-cyanohydrins DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2006-05-30 US disclosed
EP-1323830-B1 Process for the preparation of heterocyclic (R)- et (S)-cyanohydrines DSM FINE CHEM AUSTRIA GMBH (AT) 2006-04-26 EP disclosed
US-20030129712-A1 Process for preparing heterocyclic (R)- and (S)-cyanohydrins DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) 2003-07-10 US disclosed
EP-1323830-A2 Process for the preparation of heterocyclic (R)- and (S)-cyanohydrines DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) 2003-07-02 EP disclosed